| Mollie Reiko Knapp, CSWA | |
|
1750 12th St, Hood River, OR 97031-9540 | |
| (541) 386-5070 | |
| Not Available |
| Full Name | Mollie Reiko Knapp |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 8 Years |
| Location | 1750 12th St, Hood River, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083124697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | L7838 (Oregon) | Primary |
| Entity Name | Columbia Gorge Medical Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558346064 PECOS PAC ID: 8628066115 Enrollment ID: O20040504000398 |
News Archive
Diversity – at least among cancer cells – is not a good thing. Now, research from the Weizmann Institute of Science shows that in melanoma, tumors with cells that have differentiated into more diverse subtypes are less likely to be affected by the immune system, thus reducing the chance that immunotherapy will be effective.
The firestorm that followed the November 2009 release of guidelines that would have reduced use of screening mammograms in women aged 40 to 49 highlights challenges for implementing the findings of comparative effectiveness research, according to a new analysis. Meeting such challenges - which may become more common due to increased funding for CER - requires better communication to the public and stakeholders about evidence and its connection to health care quality and efficiency.
Low-tech, at-home preparation in the last month before childbirth could help pregnant mothers avoid one of the more common surgeries performed on women in the United States, a new review suggests.
Purdue researchers have identified a new class of chemical insecticides that could provide a safer, more selective means of controlling mosquitoes that transmit key infectious diseases such as dengue, yellow fever and elephantiasis.
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
› Verified 2 days ago
| Entity Name | Onyx Counseling Consulting & Supervision Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649861105 PECOS PAC ID: 4385050491 Enrollment ID: O20210315001226 |
News Archive
Diversity – at least among cancer cells – is not a good thing. Now, research from the Weizmann Institute of Science shows that in melanoma, tumors with cells that have differentiated into more diverse subtypes are less likely to be affected by the immune system, thus reducing the chance that immunotherapy will be effective.
The firestorm that followed the November 2009 release of guidelines that would have reduced use of screening mammograms in women aged 40 to 49 highlights challenges for implementing the findings of comparative effectiveness research, according to a new analysis. Meeting such challenges - which may become more common due to increased funding for CER - requires better communication to the public and stakeholders about evidence and its connection to health care quality and efficiency.
Low-tech, at-home preparation in the last month before childbirth could help pregnant mothers avoid one of the more common surgeries performed on women in the United States, a new review suggests.
Purdue researchers have identified a new class of chemical insecticides that could provide a safer, more selective means of controlling mosquitoes that transmit key infectious diseases such as dengue, yellow fever and elephantiasis.
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mollie Reiko Knapp, CSWA 1750 12th St, Hood River, OR 97031-9540 Ph: (541) 386-5070 | Mollie Reiko Knapp, CSWA 1750 12th St, Hood River, OR 97031-9540 Ph: (541) 386-5070 |
News Archive
Diversity – at least among cancer cells – is not a good thing. Now, research from the Weizmann Institute of Science shows that in melanoma, tumors with cells that have differentiated into more diverse subtypes are less likely to be affected by the immune system, thus reducing the chance that immunotherapy will be effective.
The firestorm that followed the November 2009 release of guidelines that would have reduced use of screening mammograms in women aged 40 to 49 highlights challenges for implementing the findings of comparative effectiveness research, according to a new analysis. Meeting such challenges - which may become more common due to increased funding for CER - requires better communication to the public and stakeholders about evidence and its connection to health care quality and efficiency.
Low-tech, at-home preparation in the last month before childbirth could help pregnant mothers avoid one of the more common surgeries performed on women in the United States, a new review suggests.
Purdue researchers have identified a new class of chemical insecticides that could provide a safer, more selective means of controlling mosquitoes that transmit key infectious diseases such as dengue, yellow fever and elephantiasis.
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
› Verified 2 days ago
Julie Suzanne O'donnell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 509 Cascade Ave Ste A, Hood River, OR 97031 Phone: 971-404-6504 | |
Mrs. Tawnia Danielle Anthony Berens, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4425 Willow Flat Rd, Hood River, OR 97031 Phone: 503-560-1265 | |
Dr. Naomi Victoria Mayo, LCSW, PHD Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 849 Pacific Ave, Hood River, OR 97031 Phone: 541-645-5050 | |
Mrs. Jane Leu Rekas, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 205 Oak St., Ste. 1, Hood River, OR 97031 Phone: 971-285-5679 | |
Sally C. Reichmuth, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 708 Columbia St, Hood River, OR 97031 Phone: 541-386-9191 | |
Shannon-marie O'brien, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 849 Pacific Ave, Hood River, OR 97031 Phone: 541-386-6380 |